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Background: Despite the high importance of Helicobacter pylori, the origin and transmission of this bacterium has
not been clearly determined. According to controversial theories and results of previous studies, animal source
foods – especially milk – play an important role in the transmission of H. pylori to humans. The aim of the present
study was to determine the distribution of vacA, cagA, iceA and oipA virulence factors in H. pylori strains isolated
from milk and dairy products and study their antimicrobial resistance properties.
Methods: A total of 520 raw milk and 400 traditional dairy product samples were cultured and tested. Those that
were H. pylori-positive were analyzed for the presence of vacA, cagA, iceA and oipA virulence factors. Antimicrobial
susceptibility testing was performed by the disk diffusion method.
Results: One hundred and three out of 520 milk samples (19.8%) and 77 out of 400 dairy products samples (19.2%)
were contaminated with H. pylori. The most frequently contaminated samples were ovine milk (35%) and traditional
cheese (30%). Total prevalence of vacA, cagA, iceA and oipA factors were 75%, 76.6%, 41.6% and 25%, respectively.
H. pylori strains of milk and dairy products harbored high levels of resistance to ampicillin (84.4%), tetracycline
(76.6%), erythromycin (70.5%) and metronidazole (70%).
Conclusions: High presence of antibiotic-resistant strains of H. pylori suggest that milk and dairy samples may be
the sources of bacteria that can cause severe infection. Our findings should raise awareness about antibiotic resistance
in H. pylori strains in Iran.
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Milk plays an important role in the nutrition of Iranian
people since it is considered a complete food source,
particularly for children and the elderly. Milk of animal
origin is usually manufactured into more stable dairy
products of worldwide commerce such as yogurt, cream,
butter and cheese. Every day millions of people consume
milk and dairy products. Therefore, hygienic quality of
produced milk is extremely important regarding public
health hazards.
Helicobacter pylori is a microaerophilic gram-negative
bacterium with a curved spiral shape which is known as* Correspondence: Ebrahimrahimi55@yahoo.com
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unless otherwise stated.the causative agent of type B gastritis, peptic ulcer disease,
gastric adenocarcinoma and mucosa-associated lymphoid
tissue lymphoma [1]. In spite of the general idea about the
low prevalence of gastric cancer, it is considered the fourth
most common type of cancer and the second leading
cause of cancer-related deaths worldwide [2]. A total of
1,665,540 new cancer cases and 585,720 cancer deaths are
estimated to occur in the United States in 2014 [3].
Several studies have indicated the presence of H. pylori
in the stomach of domestic animals in the absence of
gastritis [4-7]. It was also isolated in milk of sheep, goat,
cow, buffalo and camel species. These findings indicate that
domestic ruminants may be a natural host for H. pylori.
Moreover, the detection of H. pylori in the milk and
feces of domestic animals suggests that H. pylori may
be regarded as a zoonotic infection [4-7].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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milk provides opportunities for its transmission to humans
[8]. At temperatures below 30°C, H. pylori is capable of
surviving in milk and water, fresh fruit and vegetables,
fresh meat (including red meat, poultry and fish) and some
dairy products [8].
Data on the epidemiology and transmission of H. pylori
is extremely significant in order to prevent its distribution
and to identify high-risk populations, especially in areas
that have high rates of gastritis, peptic ulcers, and gastric
cancer such as Iran [5-7]. In addition to routes of trans-
mission, treatment is a critical point in the epidemiology
of H. pylori infection in humans, since therapeutic options
have become somewhat limited because of the presence of
multidrug resistant strains of this bacterium [9]. Moreover,
to the best of our knowledge, we could not find any pub-
lished data on the antibiotic resistance pattern of H. pylori
strains isolated from animal source foods.
Another aspect of H. pylori epidemiology, connected
to its pathogenicity, is related to putative virulence factors.
In fact, to determine the pathogenicity of H. pylori, as-
sessment of latent virulence factors is required. Survival
and success of pathogens require that they colonize the
host, reach an appropriate niche, avoid host defenses,
replicate, and exit the infected host to spread to an un-
infected one. In H. pylori, the genes that are mostly
associated with infections include cytotoxin-associated
gene A (cagA), vacuolating cytotoxin (vacA), outer in-
flammatory protein (oipA) and finally the gene induced
by contact with epithelium (iceA) [10,11]. These genes
are usually related to adhesion to gastric epithelial cells
[10,11].
It has been reported that the cagA gene is present in
about 60% of H. pylori isolates from clinical samples.
This gene is associated with inflammation by activation
of NF-kB and secretion of cytokines and chemokines
such as interleukin 8 (IL-8) [10,11]. The gene vacA plays
a possible role on the formation anion-selective channels
within artificial membranes and it is assumed to do the
same in vivo, increasing absorbency to anions and urea
[10,11]. Endocytosis of vacA channels leads to the forma-
tion of large vacuoles within the late endosome-lysosome
cubicle [10,11]. The function of iceA gene is not yet clear.
However, it is hypothesized that this gene is upregulated
upon contact of H. pylori with the gastric epithelium and
has been regarded as a marker for peptic ulcer diseases
[12,13]. Finally, oipA induces IL-8 secretion by epithelial
cells and increases inflammation as well as the clinically
important presentation of peptic ulcer [12,13]. Consider-
ing the unclear epidemiological aspects of H. pylori infec-
tion, the present investigation was carried out in order to
study the distribution of virulence factors and antibiotic
resistance properties of H. pylori isolated from animal milk
and dairy products.Methods
Samples
Overall, 520 raw milk samples were collected from the fol-
lowing species: bovine (n = 120), caprine (n = 100), ovine
(n = 100), buffalo (n = 80), camel (n = 60) and donkey
(n = 60). The samples were obtained from farm bulk tanks
and milk collection centers from several geographic
regions of Iran, from March 2013 to March 2014. Bovine
and buffalo samples were collected throughout this
period. Because of the seasonality of their lactating
periods, caprine, donkey and ovine milk samples were
only available in certain months (from March through
May and September to November in Iran). At each site,
sampling was performed according to the International
Dairy Federation guidelines [14]. Samples (100 mL, in
sterile glass containers) were transported to the laboratory
at 4°C within a maximum of 6 to 12 hours after collection.
For dairy products, 100 samples of cheese, 100 of butter,
100 of cream and 100 of ice cream made of raw milk were
purchased from traditional supermarkets. All selected dairy
products were made from unpasteurized milk and after
collection were kept under refrigeration in plastic bags;
information about date of production and shelf life were
not available. These products are packed manually in trad-
itional conditions and are popular among Iranian people
because of their pleasant taste and smell. Dairy product
samples were collected over a period of eight months
(between August 2013 and February 2014), and were
analyzed on the day of acquisition. Samples were trans-
ported under refrigeration (4-6°C) in thermal boxes contain-
ing ice packs and were tested immediately after collection.Isolation of Helicobacter pylori
Twenty five milliliter or grams of each sample were added
to 225 mL of Wilkins Chalgren anaerobe broth (Oxoid,
UK) supplemented with 5% of horse serum (Sigma, USA)
and colistin methanesulfonate (30 mg/L), cycloheximide
(100 mg/L), nalidixic acid (30 mg/L), trimethoprim
(30 mg/L), and vancomycin (10 mg/L) (Sigma, USA) and
incubated for seven days at 37°C under microaerophilic
conditions (86% N2, 9% CO2, 5% O2) using the Bio-Bags
(type Cfj; Becton Dickinson). Then, 0.1 mL of the enrich-
ment selective broth was plated onto Wilkins Chalgren
anaerobe agar (Oxoid, UK) supplemented with 5% of defi-
brinated horse blood and 30 mg/L colistin methanesulfo-
nate, 100 mg/L cycloheximide, 30 mg/L nalidixic acid,
30 mg/L trimethoprim, and 10 mg/L vancomycin (Sigma,
USA) [15] and incubated for seven days at 37°C under
microaerophilic conditions. Suspected colonies were
identified as H. pylori based on the morphology of the
colonies, Gram stain, and production of oxidase, cata-
lase, and urease [16]. The isolates were identified as H.
pylori by using conventional bacteriological methods, and
Table 1 Oligonucleotide primers used for detection of
vacA, cagA, oipA and iceA virulence factors of




Primer sequence (5’-3’) Size of
product (bp)
vacA F: GCCGATATGCAAATGAGCCGC 678
R: CAATCGTGTGGGTTCTGGAGC
cag A F: AATACACCAACGCCTCCAAG 400
R: TTGTTGGCGCTTGCTCTC
iceA F: CGTTGGGTAAGCGTTACAGAATTT 557
R: TCATTGTATATCCTATCATTACAAG
oip A F: GTTTTTGATGCATGGGATTT 401
R: GTGCATCTCTTATGGCTTT
Mousavi et al. Journal of Venomous Animals and Toxins including Tropical Diseases 2014, 20:51 Page 3 of 7
http://www.jvat.org/content/20/1/51were also positive by the PCR assay. For comparison,
a reference strain of H. pylori (ATCC 43504) was
employed.
Antimicrobial susceptibility testing
Pure cultures of H. pylori isolates, one strain from each
positive sample, were used for antimicrobial susceptibil-
ity testing. Tests were performed by the Kirby-Bauer disc
diffusion method using Mueller-Hinton agar (HiMedia
Laboratories, India) supplemented with 5% defibrinated
sheep blood and 7% fetal calf serum, according to the
Clinical and Laboratory Standards Institute guidelines
(CLSI) [17]. The antimicrobial resistance of H. pylori
was measured against the widely used antibiotics in cases
of H. pylori gastric ulcer. The following antimicrobial im-
pregnated disks (HiMedia Laboratories, India) were used:
metronidazole (5 μg), ampicillin (10 μg), clarithromycin
(2 μg), erythromycin (5 μg), tetracycline (30 μg), amoxicil-
lin (10 μg), levofloxacin (5 μg), trimethoprim (25 μg), cef-
sulodin (30 μg), and furazolidone (1 μg). After incubation
at 37°C for 48 hours in a microaerophilic atmosphere, the
susceptibility of the H. pylori to each antimicrobial agent
was measured and the results were interpreted in accord-
ance with criteria provided by CLSI [17]. H. pylori ATCC
43504 was used as quality control organism in antimicro-
bial susceptibility determination.
DNA extraction and Helicobacter pylori 16S rRNA gene
amplification
Suspected colonies were identified as H. pylori though
PCR technique. Genomic DNA was extracted from H.
pylori colonies using a DNA extraction kit for cells and
tissues (Roche Applied Science, Germany, 11814770001)
according to the manufacturer’s instructions. Density
of extracted DNA was assessed by optic densitometry.
Extracted DNA was amplified for the 16S rRNA gene
(primers: HP-F: 5'-CTGGAGAGACTAAGCCCTCC-3'
and HP-R: 5'-ATTACTGACGCTGATTGTGC-3') [18].
PCR reactions were performed in a final volume of
50 μL containing 5 μL 10 × buffer + MgCl2, 2 mM Dntp
(Fermentas, Germany), 2 unit Taq DNA polymerase
(Fermentas, Germany), 100 ng genomic DNA as a tem-
plate, and 25 picomole of each primer (Cinagen, Iran).
PCR was performed using a thermal cycler (Flexcycler2
Gradiant, Eppendorf, Germany) under the following con-
ditions: an initial denaturation of two minutes at 94°C;
30 cycles of 95°C for 30 seconds, 60°C for 30 seconds,
72°C for 30 seconds and a final extension at 72°C for
eight minutes.
Virulence factors of Helicobacter pylori
The list of primers used for detection of vacA, cagA,
oipA and iceA virulence factors in H. pylori is shown in
Table 1. PCR was performed in a total volume of 50 μLthat contained 1 μM of each primer, 1 μL of genomic DNA
(approximately 200 ng), 1 mM dNTPs mix (Fermentas,
Germany), 2 mM MgCl2, and 0.05 of U/μL Taq DNA poly-
merase (Fermentas, Germany). PCR amplifications were
performed in an automated thermal cycler (Mastercycler
Gradient, Eppendorf, Germany). The following cycle con-
ditions were used for PCR amplification: for vacA –
35 cycles of 30 seconds at 95°C, 60 seconds at 66°C,
and five minues at 72°C; for cagA – 35 cycles of 30 sec-
onds at 95°C, 60 seconds at 55°C, and five minutes at
72°C; for iceA – 35 cycles of 30 seconds at 95°C, 60 sec-
onds at 56°C, and five minutes at 72°C; and, finally, for
oipA – 60 seconds at 94°C, 60 seconds at 52°C and
60 seconds at 72°C. All runs included one negative
DNA control consisting of PCR grade water and two or
more positive controls (26695, J99, SS1, Tx30, 88–23,
84–183 and positive samples).
PCR products were resolved by agarose gel electro-
phoresis (5 V/60 min) using 1.5% agarose in Tris Acetate-
EDTA (TAE) buffer containing 0.5 μg/mL of ethidium
bromide (Merck, Germany). Molecular size ladder of
100 bp (Fermentas, Germany) was used to determine
the size of the bands. The gel was viewed and photo-
graphed on a Gel-Doc System (Bio-Rad, USA). All tests
were performed in triplicate.Statistical analysis
Data were transferred to Microsoft Excel spreadsheet
(Microsoft Corp., USA) for analysis. Using SPSS 16.0
statistical software (SPSS Inc., USA), chi-squared test and
Fisher’s exact two-tailed test analysis were performed and
differences were considered significant at values of p <0.05.
Distribution of virulence factors and antimicrobial resist-
ance properties of H. pylori isolated from the milk and
dairy products were statistically analyzed.
Table 2 Total distribution of Helicobacter pylori in various
types of milk and dairy products




Bovine raw milk 120 20 (16.6)
Ovine raw milk 100 35 (35)A*
Caprine raw milk 100 28 (28)
Buffalo raw milk 80 12 (15)a
Camel raw milk 60 8 (13.3)a
Donkey milk 60 –
Total milk 520 103 (19.8)
Traditional cheese 100 30 (30)B
Traditional cream 100 15 (15)
Traditional butter 100 5 (5)b
Traditional ice cream 100 27 (27)
Total dairy products 400 77 (19.2)
Total 920 180 (19.5)
*The same small and capital letters in columns indicate a significant difference
about p <0.05.
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Prevalence of Helicobacter pylori in studied samples
Eight hundred and sixty milk and dairy samples were
analyzed for the presence of H. pylori. Distribution of
H. pylori in various types of milk and dairy products is
shown in Table 2. Out of 920 milk and dairy samples,
180 (19.5%) were positive for H. pylori. Specifically,
among the positive samples, 103 out of 520 were milk
(19.8%) and 77 out of 400 consisted of dairy samples
(19.2%). Ovine milk (35%) and traditional cheese (30%)




Bovine raw milk (20) 15 (75)
Ovine raw milk (25) 22 (88)
Caprine raw milk (28) 25 (89.2)
Buffalo raw milk (12) 9 (75)
Camel raw milk (8) 5 (62.5)
Donkey raw milk (−) –
Total milk (103) 76 (73.7) 7
Traditional cheese (30) 26 (86.6)
Traditional cream (15) 10 (66.6)
Traditional butter (5) 3 (60)
Traditional ice cream (27) 20 (74)
Total dairy products (77) 59 (76.6)
Total (180) 135 (75) 1
*The same small and capital letters in rows indicate significant differences about pDistribution of virulence factors in Helicobacter pylori
isolates
Distribution of putative virulence factors in H. pylori
strains isolated from milk and dairy products is shown
in Table 3. Of 180 isolated strains of H. pylori, the distri-
bution of vacA, cagA, iceA and oipA virulence factors
were 135 (75%), 138 (76.6%), 75 (41.6%) and 45 (25%),
respectively. The most commonly detected virulence fac-
tor in H. pylori was cagA. Isolates from caprine milk and
traditional cheese had the highest incidence of putative
virulence genes.
Antimicrobial resistance pattern of Helicobacter pylori
isolates
The susceptibility of H. pylori strains to ten commonly
used commercial antimicrobial agents was studied in our
investigation. Results showed that H. pylori strains
harbored high levels of antibiotic resistance to ampicillin
(84.4%), tetracycline (76.6%), erythromycin (70.5%) and
metronidazole (70%) (Table 4). On the other hand, a lower
frequency of resistance was observed against levofloxacin
(12.7%), furazolidone (13.8%), clarithromycin (17.7%) and
cefsulodin (21.1%).
To the best of our knowledge, the present study is the
first investigation about the molecular detection of vacA,
cagA, iceA and oipA virulence factors of H. pylori strains
of bovine, ovine, caprine, buffalo and camel milk and their
derived dairy products.
Total prevalence of H. pylori in bovine, ovine, caprine,
buffalo and camel raw milk samples of our survey were
16.66%, 35%, 28%, 15% and 13.33%, respectively. Rahimi
and Kheirabadi [5] reported that the incidence of H.
pylori in raw bovine, ovine, caprine, buffalo and camelter pylori strains isolated from various types of milk and
Distribution of virulence factors (%)
cagA iceA oipA
14 (70) 10 (50) 8 (40)
23 (92) 12 (48) 5 (20)
27 (96.4) 14 (50) 10 (35.7)
10 (83.3) 4 (33.3) 2 (16.6)
5 (62.5) 2 (25) 1 (12.5)
– – –
9 (76.6)A* 42 (40.7) 26 (25.2)a
26 (86.6) 15 (50) 8 (26.6)
11 (73.3) 7 (46.6) 4 (26.6)
3 (60) 1 (20) –
19 (70.3) 10 (37) 7 (25.9)
59 (76.6)B 33 (42.8)b 19 (24.6)b
38 (76.6)C 75 (41.6) 45 (25)c
<0.05.




METR5 AM10 CLRT2 ERT5 TE30 AMX10 FZL1 Lev5 TRP25 Cef30
Bovine raw milk (20) 15 (75) 18 (90) 4 (20) 17 (85) 17 (85) 15 (75) 3 (15) 4 (20) 8 (40) 5 (25)
Ovine raw milk (25) 19 (76) 22 (88) 5 (20) 19 (76) 20 (80) 16 (64) 4 (16) 5 (20) 6 (24) 6 (24)
Caprine raw milk (28) 21 (75) 25 (89.2) 6 (21.4) 20 (71.4) 22 (78.5) 19 (67.8) 4 (14.2) 4 (14.2) 10 (35.7) 6 (21.4)
Buffalo raw milk (12) 9 (75) 10 (83.3) 3 (25) 8 (66.6) 9 (75) 9 (75) 2 (16.6) 2 (16.6) 5 (25) 3 (25)
Camel raw milk (8) 6 (75) 8 (100) 1 (12.5) 7 (87.5) 8 (100) 6 (75) – – 2 (25) 1 (12.5)
Donkey raw milk (−) – – – – – – – – – –
Total milk (103) 70 (67.9)B 83 (80.5)A* 18 (17.4)a,b 71 (68.9) 76 (73.7)C 65 (63.1) 13 (12.6)a,c 11 (10.6)a,b,c 31 (30) 21 (20.3)a
Traditional cheese (30) 23 (76.6) 26 (86.6) 6 (20) 22 (73.3) 25 (83.3) 21 (70) 6 (30) 5 (16.6) 15 (50) 7 (23.3)
Traditional cream (15) 10 (66.6) 13 (86.6) 3 (20) 11 (73.3) 12 (80) 10 (66.6) 2 (13.3) 2 (3.33) 6 (40) 4 (26.6)
Traditional butter (5) 3 (60) 5 (100) – 2 (40) 2 (40) 2 (40) – – 1 (20) 1 (20)
Traditional ice cream (27) 20 (74.0) 25 (92.5) 5 (18.5) 21 (77.7) 23 (85.1) 19 (70.3) 4 (14.8) 5 (18.5) 8 (29.6) 5 (18.5)
Total dairy products (77) 56 (72.7)C 69 (89.6)A 14 (18.1)c 56 (72.7) 62 (80.5)B 52 (67.5) 12 (15.5)b 12 (15.5)a,b,c 30 (38.9) 17 (22)a
Total (180) 126 (70) 152 (84.4)A 32 (17.7)a,c 127 (70.5)C 138 (76.6)B 117 (65) 25 (13.8) 23 (12.7)a,b,c 61 (38.8) 38 (21.1)a,b
METR5: metronidazole (5 μg/disk); AM10: ampicillin (10 μg/disk); CLRT2: clarithromycin (2 μg/disk); ERT5: erythromycin (5 μg/disk); TE30: tetracycline (30 μg/disk); AMX10: amoxicillin (10 μg/disk); FZL1: furazolidone
(1 μg/disk); Lev5: levofloxacin (5 μg/disk); TRP25: trimethoprim (25 μg/disk); Cef30: cefsulodin (30 μg/disk).
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http://www.jvat.org/content/20/1/51milk samples of Iranian herds were 1.41%, 12.2%, 8.7%,
23.4% and 3.6%, respectively. In a study carried out in
Italy, H. pylori was detected in 50%, 33%, and 25.6% of
raw bovine, sheep, and goat milk, respectively [21]. In
Japan, a study detected H. pylori in 72.2% of raw cow
milk samples [22]. Total distribution of H. pylori in milk
samples of Greek [23] and American [4] herds were
20% and 60%, respectively. Recent clinical investigation
among Iranian cows showed that 16% of milk and 40%
of feces samples of seropositive herds tested positive
for H. pylori [6].
Regarding dairy products, 30% of cheese samples were
positive for H. pylori. The temperature required for
cheesemaking is mainly low. In traditional conditions, in
order to create a better clot, the average temperature is
less than 30°C. In such circumstances and given the low
quality of primary milk and unsanitary conditions of dairy
products processing, high levels of H. pylori contamin-
ation are not unimaginable. The transformation of H.
pylori into coccoid forms may be another explanation
for the high incidence of bacteria in the observed conditions
that include acidic environment and high temperature.
Substantial discrepancy in the prevalence of H. pylori
in different studies could be related to variations in the
type of tested sample, number of samples, sampling
method, experimental methodology, geographical area,
and climate differences in the regions where the samples
were collected.
There is indirect hypothesis of H. pylori transmission
through milk, similar to that obtained for water, but less
extensive [4,6,22-24]. These studies led to the hypothesis
that H. pylori infection can be considered a zoonosis,
which is further reinforced by the occurrence of this bac-
terium in the gastric mucosa of calves, pigs, and horses
and its isolation from gastric tissue and milk of sheep [4].
Such findings suggest that these animal species may act as
reservoirs and spreaders of H. pylori. Moreover, Momtaz
et al. [7] showed that vacA s1a/m1a was frequently found
in H. pylori isolated in clinical samples of cow, sheep and
humans. They showed 3.4 to 8.4% variability and 92.9 to
98.5% homology between sheep and human samples [7].
Unfortunately, there is no previously published data
on the presence of H. pylori in dairy products. Among
the main reasons for the presence of the bacteria in dairy
products are two factors: primary contamination of milk
and cross contamination. Use of contaminated water
during dairy products processing, handling contamin-
ation, use of contaminated equipment and finally lack
of public and individual hygiene. Food safety regulations as
well as quality standards – including good agricultural prac-
tices (GAPs), good manufacturing practices (GMPs), and
hazard analysis and critical control points (HACCP) –
should be introduced in Iranian food units in order to con-
trol contamination and proliferation of pathogenic bacteria.Close association of cagA, vacA, iceA and oipA virulence
factors with interleukin 8 (IL-8) production, cytotoxin pro-
duction, gastric epithelial cells adhesion, inflammatory ef-
fects, vacuolization and apoptosis in gastric epithelial cells
has been previously observed [25-28]. High prevalence of
cagA, vacA, iceA and oipA virulence factors in cases of
gastritis, peptic ulcer and gastric cancer has been reported
in the United States, Turkey, Japan and Brazil [29-32].
Since H. pylori isolates in our study harbored cagA
(76.6%) and vacA (75%) genes, consumption of milk
and dairy products contaminated with virulent strains
may provoke duodenal ulceration, gastric mucosal atro-
phy and gastric cancer.
Another important finding of our investigation was the
high presence of antibiotic resistance among H. pylori
strains isolated from milk and dairy products. Thyagarajan
et al. [33] and Secka et al. [34] reported that H. pylori
strains from clinical samples had the highest levels of
resistance against metronidazole, amoxicillin, ampicillin
and tetracycline, which was similar to our results. In a
study conducted in India, resistance of H. pylori strains
against metronidazole, clarithromycin and amoxicillin
were 77.9%, 44.7% and 32.8%, respectively [33]. Similar
results were reported by Bang et al. [35], who found that
H. pylori isolates were highly resistant to metronidazole
(34.7%), clarithromycin (16.7%) and amoxicillin (11.8%).
The low antibiotic resistance of H. pylori against levofloxa-
cin, furazolidone, clarithromycin, trimethoprim, and cefsu-
lodin may be due to the less frequent prescription of these
antibiotics. A possible explanation for the augmented inci-
dence of antibiotic resistance in our study is the indiscrim-
inate and unnecessary veterinary use of these antibiotics.Conclusions
In Iran, milk and dairy products samples were found to
harbor H. pylori strains that possess the virulence genes
vacA, cagA, oipA and iceA. Therefore, consumption of
raw milk and their derived products by humans may be
the source of H. pylori infections. Our findings should
raise awareness on H. pylori resistance to antibiotics in
the country. Clinicians should be cautious when prescrib-
ing antibiotics, since metronidazole, ampicillin, erythro-
mycin, tetracycline and amoxicillin are not recommended
for treating H. pylori infections. Based on the present
results, we suggest the prescription of clarithromycin,
furazolidone, levofloxacin, trimethoprim and cefsulodin.Abbreviations
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